Post-traumatic stress disorder: A fast track to premature cardiovascular disease?

Cardiology in Review

Volumn 21, Issue 1, 2013, Pages 16-22

  Wentworth, Bailey A ^a   Stein, Murray B ^a   Redwine, Laura S ^a   Xue, Yang ^a,b   Taub, Pam R ^a,b   Clopton, Paul ^b   Nayak, Keshav R ^c   Maisel, Alan S ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c NAVAL MEDICAL CENTER SAN DIEGO   (United States)

Author keywords

biomarkers; cardiovascular disease; copeptinAAA; MR proADM; post traumatic stress disorder

Indexed keywords

ARGININE; VASOPRESSIN;

AUTONOMIC NERVOUS SYSTEM FUNCTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMORBIDITY; DISEASE ASSOCIATION; HUMAN; HYPERCOAGULABILITY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; METABOLIC SYNDROME X; NEUROCHEMISTRY; NEUROPHYSIOLOGY; POSTTRAUMATIC STRESS DISORDER; REVIEW; VASCULAR ENDOTHELIUM;

AUTONOMIC NERVOUS SYSTEM DISEASES; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; FORECASTING; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMMUNE SYSTEM DISEASES; METABOLIC DISEASES; PITUITARY-ADRENAL SYSTEM; RISK FACTORS; STRESS DISORDERS, POST-TRAUMATIC;

EID: 84871748027     PISSN: 10615377     EISSN: 15384683     Source Type: Journal    
DOI: 10.1097/CRD.0b013e318265343b     Document Type: Review

References (97)

1. Manguno-Mire G, Franklin LC: Post-traumatic stress disorder. In Carlstedt RA. Handbook of Integrative Clinical Psychology, Psychiatry, and Behavioral Medicine: Perspectives, Practices, and Research. New York, NY: Springer, 2009; 358-378.
2. ;NIH Fact Sheets - Post-Traumatic Stress Disorder (PTSD).; NIH Research Portfolio Online Reporting Tools (RePORT). National Institute of Mental Health. Available at: http://report.nih.gov/NIHfactsheets/ViewFactSheet. aspx?csid=58.
3. Litz BT, Schlenger WE. PTSD in service members and new veterans of the Iraq and Afghanistan wars: a bibliography and critique. PTSD Research Quarterly. 2009; 20:1-3.
4. Boscarino JA. Diseases among men 20 years after exposure to severe stress: implications for clinical research and medical care. Psychosom Med. 1997;59:605-614. (Pubitemid 27513697)
5. Boscarino JA. External-cause mortality after psychologic trauma: the effects of stress exposure and predisposition. Compr Psychiatry. 2006;47:503-514. (Pubitemid 44602014)
6. Kang HK, Bullman TA, Taylor JW. Risk of selected cardiovascular diseases and posttraumatic stress disorder among former World War II prisoners of war. Ann Epidemiol. 2006;16:381-386.
7. Kubzansky LD, Koenen KC, Jones C, et al. A prospective study of posttraumatic stress disorder symptoms and coronary heart disease in women. Health Psychol. 2009;28:125-130.
8. Kubzansky LD, Koenen KC, Spiro A 3rd, et al. Prospective study of posttraumatic stress disorder symptoms and coronary heart disease in the Normative Aging Study. Arch Gen Psychiatry. 2007;64:109-116. (Pubitemid 46041744)
9. Boscarino JA, Chang J. Electrocardiogram abnormalities among men with stress-related psychiatric disorders: implications for coronary heart disease and clinical research. Ann Behav Med. 1999;21:227-234.
10. Kibler JL. Posttraumatic stress and cardiovascular disease risk. J Trauma Dissociation. 2009;10:135-150.
11. Cohen BE, Marmar C, Ren L, et al. Association of cardiovascular risk factors with mental health diagnoses in Iraq and Afghanistan war veterans using VA health care. JAMA. 2009;302:489-492.
12. Schnurr PP, Spiro A 3rd, Paris AH. Physician-diagnosed medical disorders in relation to PTSD symptoms in older male military veterans. Health Psychol. 2000;19:91-97.
13. McFarlane AC. The long-term costs of traumatic stress: intertwined physical and psychological consequences. World Psychiatry. 2010;9:3-10.
14. Dedert EA, Calhoun PS, Watkins LL, et al. Posttraumatic stress disorder, cardiovascular, and metabolic disease: a review of the evidence. Ann Behav Med. 2010;39:61-78.
15. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: 4th ed. 2000.
16. Tsigos C, Chrousos GP. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res. 2002;53:865-871. (Pubitemid 35282615)
17. Yehuda R. Advances in understanding neuroendocrine alterations in PTSD and their therapeutic implications. Ann N Y Acad Sci. 2006;1071:137-166. (Pubitemid 44126726)
18. de Kloet CS, Vermetten E, Geuze E, et al. Assessment of HPA-axis function in posttraumatic stress disorder: pharmacological and non-pharmacological challenge tests, a review. J Psychiatr Res. 2006;40:550-567. (Pubitemid 44175408)
19. Blechert J, Michael T, Grossman P, et al. Autonomic and respiratory characteristics of posttraumatic stress disorder and panic disorder. Psychosom Med. 2007;69:935-943. (Pubitemid 350158837)
20. Baker DG, West SA, Nicholson WE, et al. Serial CSF corticotropin- releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder. Am J Psychiatry. 1999;156:585-588. (Pubitemid 29162980)
21. Bremner JD, Vythilingam M, Anderson G, et al. Assessment of the hypothalamic-pituitary-adrenal axis over a 24-hour diurnal period and in response to neuroendocrine challenges in women with and without childhood sexual abuse and posttraumatic stress disorder. Biol Psychiatry. 2003;54:710-718. (Pubitemid 37281387)
22. Yehuda R, Southwick SM, Krystal JH, et al. Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder. Am J Psychiatry. 1993;150:83-86. (Pubitemid 23059168)
23. Fries E: Hypercortisolemic disorders. In: Hellhammer DH, Hellhammer J, eds. Stress: The Brain-Body Connection.(Key Issues in Mental Health), vol. 174. Basel, Switzerland: Karger; 2008:60-77.
24. Yehuda R, Golier JA, Kaufman S. Circadian rhythm of salivary cortisol in Holocaust survivors with and without PTSD. Am J Psychiatry. 2005;162:998-1000. (Pubitemid 40676216)
25. Vreeburg SA, Kruijtzer BP, van Pelt J, et al. Associations between sociodemographic, sampling and health factors and various salivary cortisol indicators in a large sample without psychopathology. Psychoneuroendocrinology. 2009;34:1109-1120.
26. Nater UM, Youngblood LS, Jones JF, et al. Alterations in diurnal salivary cortisol rhythm in a population-based sample of cases with chronic fatigue syndrome. Psychosom Med. 2008;70:298-305. (Pubitemid 351543501)
27. Heim C, Nemeroff CB. Neurobiology of posttraumatic stress disorder. CNS Spectr. 2009;14(1 Suppl 1):13-24.
28. Yehuda R, Southwick S, Giller EL, et al. Urinary catecholamine excretion and severity of PTSD symptoms in Vietnam combat veterans. J Nerv Ment Dis. 1992;180:321-325.
29. Buckley TC, Kaloupek DG. A meta-analytic examination of basal cardiovascular activity in posttraumatic stress disorder. Psychosom Med. 2001;63:585-594. (Pubitemid 32695139)
30. Orr SP, Metzger LJ, Lasko NB, et al.; Harvard/Veterans Affairs Post-traumatic Stress Disorder Twin Study Investigators. Physiologic responses to sudden, loud tones in monozygotic twins discordant for combat exposure: association with posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60:283-288. (Pubitemid 36307439)
31. Thayer JF, Yamamoto SS, Brosschot JF. The relationship of autonomic imbalance, heart rate variability and cardiovascular disease risk factors. Int J Cardiol. 2010;141:122-131.
32. Sack M, Hopper JW, Lamprecht F. Low respiratory sinus arrhythmia and prolonged psychophysiological arousal in posttraumatic stress disorder: heart rate dynamics and individual differences in arousal regulation. Biol Psychiatry. 2004;55:284-290. (Pubitemid 38117165)
33. Cohen H, Benjamin J. Power spectrum analysis and cardiovascular morbidity in anxiety disorders. Auton Neurosci. 2006;128:1-8. (Pubitemid 43903407)
34. Sahar T, Shalev AY, Porges SW. Vagal modulation of responses to mental challenge in posttraumatic stress disorder. Biol Psychiatry. 2001;49: 637-643. (Pubitemid 32289358)
35. Gardner DG, Shoback DM, Greenspan FS. Greenspan's Basic & Clinical Endocrinology. New York, NY: McGraw-Hill Medical; 2007.
36. Maisel A, Mueller C, Nowak RM, et al. Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. J Am Coll Cardiol. 2011;58:1057-1067.
37. Xue Y, Taub PR, Iqbal N, et al. Cardiac biomarkers, mortality, and post-traumatic stress disorder in military veterans. Am J Cardiol. 2012;109:1215-1218.
38. Greenland P, Daviglus ML, Dyer AR, et al. Resting heart rate is a risk factor for cardiovascular and noncardiovascular mortality: the Chicago Heart Association Detection Project in Industry. Am J Epidemiol. 1999;149:853-862. (Pubitemid 29196698)
39. Lefkowitz RJ, Rockman HA, Koch WJ. Catecholamines, cardiac beta-adrenergic receptors, and heart failure. Circulation. 2000;101:1634-1637. (Pubitemid 30196619)
40. Friedman RA: Why are we drugging our soldiers? (opinion). NY Times. April 21, 2012.
41. Szczepanska-Sadowska E, Cudnoch-Jedrzejewska A, Ufnal M, et al. Brain and cardiovascular diseases: common neurogenic background of cardiovascular, metabolic and inflammatory diseases. J Physiol Pharmacol. 2010;61:509-521.
42. Surget A, Belzung C. Involvement of vasopressin in affective disorders. Eur J Pharmacol. 2008;583:340-349.
43. de Kloet CS, Vermetten E, Geuze E, et al. Elevated plasma arginine vasopressin levels in veterans with posttraumatic stress disorder. J Psychiatr Res. 2008;42:192-198. (Pubitemid 350266721)
44. Ryckmans T. Modulation of the vasopressin system for the treatment of CNS diseases. Curr Opin Drug Discov Devel. 2010;13:538-547.
45. Piçarra BC, Dionísio P, Jara A. The role of antidiuretic hormone in the pathophysiology and treatment of heart failure. Rev Port Cardiol. 2009;28:971-983.
46. Li X, Chan TO, Myers V, et al. Controlled and cardiac-restricted overexpression of the arginine vasopressin V1A receptor causes reversible left ventricular dysfunction through Gaq-mediated cell signaling. Circulation. 2011;124:572-581.
47. Cudnoch-Jedrzejewska A, Szczepanska-Sadowska E, Dobruch J, et al. Brain vasopressin V(1) receptors contribute to enhanced cardiovascular responses to acute stress in chronically stressed rats and rats with myocardial infarcton. Am J Physiol Regul Integr Comp Physiol. 2010;298:R672-R680.
48. Morgenthaler NG. Copeptin: a biomarker of cardiovascular and renal function. Congest Heart Fail. 2010;16(Suppl 1):S37-S44.
49. Voors AA, von Haehling S, Anker SD, et al.; OPTIMAAL Investigators. C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study. Eur Heart J. 2009;30:1187-1194.
50. Maisel A, Xue Y, Shah K, et al. Increased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the Biomarkers in Acute Heart Failure (BACH) study. Circ Heart Fail. 2011;4:613-620.
51. Nikolaus S, Antke C, Beu M, et al. Cortical GABA, striatal dopamine and midbrain serotonin as the key players in compulsive and anxiety disorders- results from in vivo imaging studies. Rev Neurosci. 2010;21:119-139.
52. Fernández N, Jancar S, Sánchez Crespo M. Blood and endothelium in immune complex-mediated tissue injury. Trends Pharmacol Sci. 2004;25:512-517.
53. Boscarino JA. Posttraumatic stress disorder and physical illness: results from clinical and epidemiologic studies. Ann N Y Acad Sci. 2004;1032:141-153. (Pubitemid 40298466)
54. Altemus M, Dhabhar FS, Yang R. Immune function in PTSD. Ann N Y Acad Sci. 2006;1071:167-183. (Pubitemid 44126727)
55. Vidovic A, Vilibic M, Sabioncello A, et al. Circulating lymphocyte subsets, natural killer cell cytotoxicity, and components of hypothalamic-pituitary-adrenal axis in Croatian war veterans with posttraumatic stress disorder: cross-sectional study. Croat Med J. 2007;48:198-206. (Pubitemid 46651026)
56. Gill JM, Saligan L, Woods S, et al. PTSD is associated with an excess of inflammatory immune activities. Perspect Psychiatr Care. 2009;45:262-277.
57. Kawamura N, Kim Y, Asukai N. Suppression of cellular immunity in men with a past history of posttraumatic stress disorder. Am J Psychiatry. 2001;158:484-486. (Pubitemid 32205210)
58. Lemieux A, Coe CL, Carnes M. Symptom severity predicts degree of T cell activation in adult women following childhood maltreatment. Brain Behav Immun. 2008;22:994-1003.
59. Tucker P, Ruwe WD, Masters B, et al. Neuroimmune and cortisol changes in selective serotonin reuptake inhibitor and placebo treatment of chronic posttraumatic stress disorder. Biol Psychiatry. 2004;56:121-128. (Pubitemid 38844787)
60. Spivak B, Shohat B, Mester R, et al. Elevated levels of serum interleukin-1 beta in combat-related posttraumatic stress disorder. Biol Psychiatry. 1997;42:345-348. (Pubitemid 27380968)
61. von Känel R, Hepp U, Kraemer B, et al. Evidence for low-grade systemic proinflammatory activity in patients with posttraumatic stress disorder. J Psychiatr Res. 2007;41:744-752. (Pubitemid 46659723)
62. Song Y, Zhou D, Guan Z, et al. Disturbance of serum interleukin-2 and interleukin-8 levels in posttraumatic and non-posttraumatic stress disorder earthquake survivors in northern China. Neuroimmunomodulation. 2007;14:248-254. (Pubitemid 351339991)
63. Pervanidou P, Kolaitis G, Charitaki S, et al. Elevated morning serum interleukin (IL)-6 or evening salivary cortisol concentrations predict posttraumatic stress disorder in children and adolescents six months after a motor vehicle accident. Psychoneuroendocrinology. 2007;32:991-999. (Pubitemid 350086813)
64. Miller RJ, Sutherland AG, Hutchison JD, et al. C-reactive protein and interleukin 6 receptor in post-traumatic stress disorder: a pilot study. Cytokine. 2001;13:253-255. (Pubitemid 32575458)
65. Söndergaard HP, Hansson LO, Theorell T. The inflammatory markers C-reactive protein and serum amyloid A in refugees with and without posttraumatic stress disorder. Clin Chim Acta. 2004;342:93-98. (Pubitemid 38352917)
66. Pace TW, Heim CM. A short review on the psychoneuroimmunology of posttraumatic stress disorder: from risk factors to medical comorbidities. Brain Behav Immun. 2011;25:6-13.
67. Bergmann M, Sautner T. Immunomodulatory effects of vasoactive catecholamines. Wien Klin Wochenschr. 2002;114:752-761.
68. Uddin M, Aiello AE, Wildman DE, et al. Epigenetic and immune function profiles associated with posttraumatic stress disorder. Proc Natl Acad Sci USA. 2010;107:9470-9475.
69. Violanti JM, Andrew M, Burchfiel CM, et al. Post-traumatic stress symptoms and cortisol patterns among police officers. Policing: An Intl J Police Strategies & Mgmt. 2007;30:189-202.
70. Ahmadi N, Hajsadeghi F, Mirshkarlo HB, et al. Post-traumatic stress disorder, coronary atherosclerosis, and mortality. Am J Cardiol. 2011;108:29-33.
71. von Känel R, Hepp U, Traber R, et al. Measures of endothelial dysfunction in plasma of patients with posttraumatic stress disorder. Psychiatry Res. 2008;158:363-373.
72. von Känel R, Hepp U, Buddeberg C, et al. Altered blood coagulation in patients with posttraumatic stress disorder. Psychosom Med. 2006;68:598-604. (Pubitemid 44297657)
73. Vidovic A, Grubišic-Ilic M, Kozaric-Kovacic D, et al. Exaggerated platelet reactivity to physiological agonists in war veterans with posttraumatic stress disorder. Psychoneuroendocrinology. 2011;36:161-172.
74. Montoro-García S, Shantsila E, Lip GY. Platelet reactivity in prolonged stress disorders-a link with cardiovascular disease? Psychoneuroendocrinology. 2011;36:159-160.
75. von Känel R, Abbas CC, Begré S, et al. Posttraumatic stress disorder and soluble cellular adhesion molecules at rest and in response to a trauma-specific interview in patients after myocardial infarction. Psychiatry Res. 2010;179:312-317.
76. Maia DB, Marmar CR, Mendlowicz MV, et al. Abnormal serum lipid profile in Brazilian police officers with post-traumatic stress disorder. J Affect Disord. 2008;107:259-263. (Pubitemid 351288923)
77. Solter V, Thaller V, Karlovic D, et al. Elevated serum lipids in veterans with combat-related chronic posttraumatic stress disorder. Croat Med J. 2002;43:685-689. (Pubitemid 41490283)
78. Kagan BL, Leskin G, Haas B, et al. Elevated lipid levels in Vietnam veterans with chronic posttraumatic stress disorder. Biol Psychiatry. 1999;45:374-377. (Pubitemid 29100047)
79. Dzubur Kulenovic A, Kucukalic A, Malec D. Changes in plasma lipid concentrations and risk of coronary artery disease in army veterans suffering from chronic posttraumatic stress disorder. Croat Med J. 2008;49:506-514.
80. Karlovic D, Buljan D, Martinac M, et al. Serum lipid concentrations in Croatian veterans with post-traumatic stress disorder, post-traumatic stress disorder comorbid with major depressive disorder, or major depressive disorder. J Korean Med Sci. 2004;19:431-436. (Pubitemid 38859836)
81. Violanti JM, Fekedulegn D, Hartley TA, et al. Police trauma and cardiovascular disease: association between PTSD symptoms and metabolic syndrome. Int J Emerg Ment Health. 2006;8:227-237.
82. Heppner PS, Crawford EF, Haji UA, et al. The association of posttraumatic stress disorder and metabolic syndrome: a study of increased health risk in veterans. BMC Med. 2009;7:1.
83. Vieweg WV, Julius DA, Bates J, et al. Posttraumatic stress disorder as a risk factor for obesity among male military veterans. Acta Psychiatr Scand. 2007;116:483-487. (Pubitemid 350086146)
84. Dedert EA, Becker ME, Fuemmeler BF, et al. Childhood traumatic stress and obesity in women: the intervening effects of PTSD and MDD. J Trauma Stress. 2010;23:785-763.
85. Pederson CL, Wilson JF. Childhood emotional neglect related to posttraumatic stress disorder symptoms and body mass index in adult women. Psychol Rep. 2009;105:111-126.
86. Liao SC, Lee MB, Lee YJ, et al. Hyperleptinemia in subjects with persistent partial posttraumatic stress disorder after a major earthquake. Psychosom Med. 2004;66:23-28.
87. von Känel R, Begré S, Abbas CC, et al. Inflammatory biomarkers in patients with posttraumatic stress disorder caused by myocardial infarction and the role of depressive symptoms. Neuroimmunomodulation. 2010;17:39-46.
88. Rasmusson AM, Hauger RL, Morgan CA, et al. Low baseline and yohimbine-stimulated plasma neuropeptide Y (NPY) levels in combat-related PTSD. Biol Psychiatry. 2000;47:526-539. (Pubitemid 30129081)
89. Yehuda R, Brand S, Yang RK. Plasma neuropeptide Y concentrations in combat exposed veterans: relationship to trauma exposure, recovery from PTSD, and coping. Biol Psychiatry. 2006;59:660-663. (Pubitemid 43357961)
90. Sah R, Ekhator NN, Strawn JR, et al. Low cerebrospinal fluid neuropeptide Y concentrations in posttraumatic stress disorder. Biol Psychiatry. 2009;66:705-707.
91. Strawn JR, Pyne-Geithman GJ, Ekhator NN, et al. Low cerebrospinal fluid and plasma orexin-A (hypocretin-1) concentrations in combat-related posttraumatic stress disorder. Psychoneuroendocrinology. 2010;35:1001-1007.
92. Taylor VH, Macqueen GM. The role of adipokines in understanding the associations between obesity and depression. J Obes. 2010;2010.
93. Walczewska J, Rutkowski K, Wizner B, et al. Stiffness of large arteries and cardiovascular risk in patients with post-traumatic stress disorder. Eur Heart J. 2011;32:730-736.
94. Kinzie JD, Riley C, McFarland B, et al. High prevalence rates of diabetes and hypertension among refugee psychiatric patients. J Nerv Ment Dis. 2008;196:108-112. (Pubitemid 351253422)
95. Cohen H, Kozlovsky N, Savion N, et al. An association between stress-induced disruption of the hypothalamic-pituitary-adrenal axis and disordered glucose metabolism in an animal model of post-traumatic stress disorder. J Neuroendocrinol. 2009;21:898-909.
96. Braunwald E. Biomarkers in heart failure. N Engl J Med. 2008;358: 2148-2159.
97. Hohensinner PJ, Niessner A, Huber K, et al. Inflammation and cardiac outcome. Curr Opin Infect Dis. 2011;24:259-264.